Literature DB >> 24286128

Survival of HIV-positive individuals with hepatitis B and C infection in Michigan.

Z A Butt1, M J Wilkins2, E Hamilton3, D Todem1, J C Gardiner1, M Saeed1.   

Abstract

We sought to estimate mortality and associated factors in HIV-hepatitis co-infected individuals in Michigan using a retrospective cohort study. For the study period of 1 January 2006 to 31 December 2009, all HIV-infected individuals were matched to hepatitis B and C cases. In the final Cox proportional hazards regression model, individuals of other [hazard ratio (HR) 2·2, 95% confidence interval (CI) 1·4-3·2] and black (HR 1·3, 95% CI 1·1-1·6) race had decreased survival compared to white race. Similarly, injecting drug users (IDUs) (HR 2·1, 95% CI 1·6-2·6), men who have sex with men (MSM)/IDUs (HR 1·5, 95% CI 1·1-2·2), individuals with undetermined risk (HR 1·5, 95% CI 1·2-1·9) and heterosexual practices (HR 1·4, 95% CI 1·1-1·8) had decreased survival compared to MSM. Additionally, an interaction was found between current HIV status and co-infection. Mortality in HIV-hepatitis co-infected individuals remains a continuing problem. Our study can help in planning interventions to reduce mortality in HIV-infected individuals.

Entities:  

Mesh:

Year:  2013        PMID: 24286128      PMCID: PMC9151294          DOI: 10.1017/S0950268813003038

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  34 in total

1.  Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value.

Authors:  J Ockenga; H L Tillmann; C Trautwein; M Stoll; M P Manns; R E Schmidt
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

Review 2.  Hepatitis C and human immunodeficiency virus infection.

Authors:  David L Thomas
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

3.  Mortality in siblings of patients coinfected with HIV and hepatitis C virus.

Authors:  Ann-Brit Eg Hansen; Jan Gerstoft; Gitte Kronborg; Court Pedersen; Henrik Toft Sorensen; Niels Obel
Journal:  J Infect Dis       Date:  2006-12-11       Impact factor: 5.226

4.  Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.

Authors:  Deborah Konopnicki; Amanda Mocroft; S de Wit; Francisco Antunes; Bruno Ledergerber; Christine Katlama; K Zilmer; Stefano Vella; Ole Kirk; Jens D Lundgren
Journal:  AIDS       Date:  2005-03-24       Impact factor: 4.177

5.  Characteristics and survival of AIDS patients with hepatitis C: the Brazilian National Cohort of 1995-1996.

Authors:  José Ricardo Pio Marins; Marilisa Berti de Azevedo Barros; Helymar Machado; Sanny Chen; Leda Fátima Jamal; Norman Hearst
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

6.  Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients.

Authors:  Joel Emery; Neora Pick; Edward J Mills; Curtis L Cooper
Journal:  Patient Prefer Adherence       Date:  2010-05-13       Impact factor: 2.711

7.  Hepatitis C and progression of HIV disease.

Authors:  Mark S Sulkowski; Richard D Moore; Shruti H Mehta; Richard E Chaisson; David L Thomas
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

8.  Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis.

Authors:  Georgios K Nikolopoulos; Dimitrios Paraskevis; Eleni Hatzitheodorou; Zissis Moschidis; Vana Sypsa; Xenophon Zavitsanos; Victoria Kalapothaki; Angelos Hatzakis
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

9.  Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States.

Authors:  Jong-Hun Kim; George Psevdos; Jin Suh; Victoria-Lee Sharp
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

10.  Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic.

Authors:  Wang-Huei Sheng; Mao-Yuan Chen; Szu-Min Hsieh; Chin-Fu Hsiao; Jann-Tay Wang; Chien-Ching Hung; Shan-Chwen Chang
Journal:  Clin Infect Dis       Date:  2004-04-28       Impact factor: 9.079

View more
  3 in total

1.  Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes.

Authors:  Zahid A Butt; Stanley Wong; Carmine Rossi; Mawuena Binka; Jason Wong; Amanda Yu; Maryam Darvishian; Maria Alvarez; Nuria Chapinal; Geoff Mckee; Mark Gilbert; Mark W Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  Open Forum Infect Dis       Date:  2020-08-13       Impact factor: 3.835

2.  A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.

Authors:  Zahid Ahmad Butt; Nabin Shrestha; Stanley Wong; Margot Kuo; Dionne Gesink; Mark Gilbert; Jason Wong; Amanda Yu; Maria Alvarez; Hasina Samji; Jane A Buxton; James C Johnston; Victoria J Cook; David Roth; Theodora Consolacion; Michelle Murti; Travis S Hottes; Gina Ogilvie; Robert Balshaw; Mark W Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

3.  Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals.

Authors:  Zahid A Butt; Nabin Shrestha; Dionne Gesink; Michelle Murti; Jane A Buxton; Mark Gilbert; Robert F Balshaw; Stanley Wong; Margot Kuo; Jason Wong; Amanda Yu; Maria Alvarez; Hasina Samji; David Roth; Theodora Consolacion; Mark W Hull; Gina Ogilvie; Mark W Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  Clin Epidemiol       Date:  2018-08-31       Impact factor: 4.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.